nodes	percent_of_prediction	percent_of_DWPC	metapath
Secobarbital—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.198	0.259	CbGbCtD
Secobarbital—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.138	0.181	CbGbCtD
Secobarbital—CYP2C8—Progesterone—uterine cancer	0.131	0.172	CbGbCtD
Secobarbital—CYP1A2—Progesterone—uterine cancer	0.101	0.133	CbGbCtD
Secobarbital—CYP2C9—Progesterone—uterine cancer	0.0913	0.12	CbGbCtD
Secobarbital—CYP2C8—Etoposide—uterine cancer	0.0586	0.0768	CbGbCtD
Secobarbital—CYP1A2—Etoposide—uterine cancer	0.0454	0.0594	CbGbCtD
Secobarbital—CHRFAM7A—corpus luteum—uterine cancer	0.0448	0.404	CbGeAlD
Secobarbital—CHRNA7—corpus luteum—uterine cancer	0.0362	0.326	CbGeAlD
Secobarbital—Hepatocellular injury—Progesterone—uterine cancer	0.00426	0.0338	CcSEcCtD
Secobarbital—Depressed level of consciousness—Progesterone—uterine cancer	0.00412	0.0327	CcSEcCtD
Secobarbital—Hepatocellular injury—Medroxyprogesterone Acetate—uterine cancer	0.00386	0.0306	CcSEcCtD
Secobarbital—Injection site reaction—Medroxyprogesterone Acetate—uterine cancer	0.00384	0.0305	CcSEcCtD
Secobarbital—Mental disability—Progesterone—uterine cancer	0.0037	0.0293	CcSEcCtD
Secobarbital—GABRA4—mammalian vulva—uterine cancer	0.00313	0.0282	CbGeAlD
Secobarbital—CHRNA7—renal system—uterine cancer	0.00289	0.0261	CbGeAlD
Secobarbital—CHRFAM7A—female reproductive system—uterine cancer	0.00287	0.0259	CbGeAlD
Secobarbital—Ataxia—Medroxyprogesterone Acetate—uterine cancer	0.00264	0.0209	CcSEcCtD
Secobarbital—CHRFAM7A—female gonad—uterine cancer	0.00261	0.0236	CbGeAlD
Secobarbital—CHRNA7—uterus—uterine cancer	0.00258	0.0233	CbGeAlD
Secobarbital—Apnoea—Etoposide—uterine cancer	0.00257	0.0204	CcSEcCtD
Secobarbital—CHRNA7—female reproductive system—uterine cancer	0.00232	0.0209	CbGeAlD
Secobarbital—Body temperature increased—Carboplatin—uterine cancer	0.00229	0.0182	CcSEcCtD
Secobarbital—CHRNA7—female gonad—uterine cancer	0.00211	0.019	CbGeAlD
Secobarbital—Bradycardia—Medroxyprogesterone Acetate—uterine cancer	0.00197	0.0157	CcSEcCtD
Secobarbital—GABRA2—vagina—uterine cancer	0.00185	0.0167	CbGeAlD
Secobarbital—Tension—Progesterone—uterine cancer	0.00183	0.0145	CcSEcCtD
Secobarbital—Nervousness—Progesterone—uterine cancer	0.00181	0.0144	CcSEcCtD
Secobarbital—Angioedema—Progesterone—uterine cancer	0.0017	0.0135	CcSEcCtD
Secobarbital—Syncope—Progesterone—uterine cancer	0.00167	0.0133	CcSEcCtD
Secobarbital—Tension—Medroxyprogesterone Acetate—uterine cancer	0.00166	0.0131	CcSEcCtD
Secobarbital—Nervousness—Medroxyprogesterone Acetate—uterine cancer	0.00164	0.013	CcSEcCtD
Secobarbital—Loss of consciousness—Progesterone—uterine cancer	0.00164	0.013	CcSEcCtD
Secobarbital—CYP2C8—renal system—uterine cancer	0.00162	0.0146	CbGeAlD
Secobarbital—Anxiety—Progesterone—uterine cancer	0.00158	0.0125	CcSEcCtD
Secobarbital—CYP2C8—endometrium—uterine cancer	0.00157	0.0142	CbGeAlD
Secobarbital—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00155	0.0123	CcSEcCtD
Secobarbital—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.00154	0.0122	CcSEcCtD
Secobarbital—Confusional state—Progesterone—uterine cancer	0.00153	0.0122	CcSEcCtD
Secobarbital—CYP1A2—renal system—uterine cancer	0.00152	0.0137	CbGeAlD
Secobarbital—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.00151	0.012	CcSEcCtD
Secobarbital—Shock—Progesterone—uterine cancer	0.0015	0.0119	CcSEcCtD
Secobarbital—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00148	0.0118	CcSEcCtD
Secobarbital—Liver injury—Epirubicin—uterine cancer	0.00145	0.0115	CcSEcCtD
Secobarbital—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.00143	0.0114	CcSEcCtD
Secobarbital—Hypotension—Progesterone—uterine cancer	0.00142	0.0113	CcSEcCtD
Secobarbital—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00139	0.011	CcSEcCtD
Secobarbital—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00136	0.0108	CcSEcCtD
Secobarbital—Somnolence—Progesterone—uterine cancer	0.00135	0.0107	CcSEcCtD
Secobarbital—Liver injury—Doxorubicin—uterine cancer	0.00134	0.0107	CcSEcCtD
Secobarbital—Thinking abnormal—Epirubicin—uterine cancer	0.00133	0.0106	CcSEcCtD
Secobarbital—CYP2C8—female reproductive system—uterine cancer	0.0013	0.0117	CbGeAlD
Secobarbital—Constipation—Progesterone—uterine cancer	0.0013	0.0103	CcSEcCtD
Secobarbital—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00129	0.0102	CcSEcCtD
Secobarbital—Feeling abnormal—Progesterone—uterine cancer	0.00125	0.00994	CcSEcCtD
Secobarbital—Thinking abnormal—Doxorubicin—uterine cancer	0.00124	0.0098	CcSEcCtD
Secobarbital—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00122	0.00972	CcSEcCtD
Secobarbital—Hepatocellular injury—Epirubicin—uterine cancer	0.00122	0.0097	CcSEcCtD
Secobarbital—Injection site reaction—Epirubicin—uterine cancer	0.00121	0.00964	CcSEcCtD
Secobarbital—Body temperature increased—Progesterone—uterine cancer	0.0012	0.00954	CcSEcCtD
Secobarbital—GABRA2—lymph node—uterine cancer	0.0012	0.0108	CbGeAlD
Secobarbital—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00118	0.00935	CcSEcCtD
Secobarbital—CYP2C8—vagina—uterine cancer	0.00118	0.0106	CbGeAlD
Secobarbital—CYP2C9—female reproductive system—uterine cancer	0.00116	0.0104	CbGeAlD
Secobarbital—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00114	0.00901	CcSEcCtD
Secobarbital—Hepatocellular injury—Doxorubicin—uterine cancer	0.00113	0.00897	CcSEcCtD
Secobarbital—Injection site reaction—Doxorubicin—uterine cancer	0.00112	0.00892	CcSEcCtD
Secobarbital—Hypersensitivity—Progesterone—uterine cancer	0.00112	0.00889	CcSEcCtD
Secobarbital—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.00864	CcSEcCtD
Secobarbital—Mental disability—Epirubicin—uterine cancer	0.00106	0.00841	CcSEcCtD
Secobarbital—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00805	CcSEcCtD
Secobarbital—Dizziness—Progesterone—uterine cancer	0.00101	0.00798	CcSEcCtD
Secobarbital—Mental disability—Doxorubicin—uterine cancer	0.000981	0.00779	CcSEcCtD
Secobarbital—Vomiting—Progesterone—uterine cancer	0.000967	0.00767	CcSEcCtD
Secobarbital—Rash—Progesterone—uterine cancer	0.000959	0.00761	CcSEcCtD
Secobarbital—Dermatitis—Progesterone—uterine cancer	0.000958	0.0076	CcSEcCtD
Secobarbital—Headache—Progesterone—uterine cancer	0.000953	0.00756	CcSEcCtD
Secobarbital—Dermatitis exfoliative—Epirubicin—uterine cancer	0.00094	0.00746	CcSEcCtD
Secobarbital—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000911	0.00723	CcSEcCtD
Secobarbital—Nausea—Progesterone—uterine cancer	0.000903	0.00717	CcSEcCtD
Secobarbital—Feeling abnormal—Dactinomycin—uterine cancer	0.000886	0.00703	CcSEcCtD
Secobarbital—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000876	0.00695	CcSEcCtD
Secobarbital—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.00087	0.0069	CcSEcCtD
Secobarbital—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000869	0.00689	CcSEcCtD
Secobarbital—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000868	0.00689	CcSEcCtD
Secobarbital—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000863	0.00685	CcSEcCtD
Secobarbital—Body temperature increased—Dactinomycin—uterine cancer	0.00085	0.00674	CcSEcCtD
Secobarbital—Loss of consciousness—Etoposide—uterine cancer	0.000838	0.00665	CcSEcCtD
Secobarbital—Ataxia—Epirubicin—uterine cancer	0.000834	0.00662	CcSEcCtD
Secobarbital—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000818	0.00649	CcSEcCtD
Secobarbital—Hypersensitivity—Dactinomycin—uterine cancer	0.000792	0.00628	CcSEcCtD
Secobarbital—Confusional state—Etoposide—uterine cancer	0.000784	0.00622	CcSEcCtD
Secobarbital—Ataxia—Doxorubicin—uterine cancer	0.000772	0.00612	CcSEcCtD
Secobarbital—Hypotension—Etoposide—uterine cancer	0.000727	0.00577	CcSEcCtD
Secobarbital—Somnolence—Etoposide—uterine cancer	0.000691	0.00549	CcSEcCtD
Secobarbital—Vomiting—Dactinomycin—uterine cancer	0.000683	0.00542	CcSEcCtD
Secobarbital—Rash—Dactinomycin—uterine cancer	0.000678	0.00538	CcSEcCtD
Secobarbital—Constipation—Etoposide—uterine cancer	0.000665	0.00528	CcSEcCtD
Secobarbital—Feeling abnormal—Etoposide—uterine cancer	0.000641	0.00509	CcSEcCtD
Secobarbital—Nausea—Dactinomycin—uterine cancer	0.000638	0.00507	CcSEcCtD
Secobarbital—Bradycardia—Epirubicin—uterine cancer	0.000625	0.00496	CcSEcCtD
Secobarbital—Body temperature increased—Etoposide—uterine cancer	0.000615	0.00488	CcSEcCtD
Secobarbital—Bradycardia—Doxorubicin—uterine cancer	0.000578	0.00459	CcSEcCtD
Secobarbital—Hypersensitivity—Etoposide—uterine cancer	0.000573	0.00455	CcSEcCtD
Secobarbital—Tension—Epirubicin—uterine cancer	0.000524	0.00416	CcSEcCtD
Secobarbital—Nervousness—Epirubicin—uterine cancer	0.000519	0.00412	CcSEcCtD
Secobarbital—Dizziness—Etoposide—uterine cancer	0.000514	0.00408	CcSEcCtD
Secobarbital—Vomiting—Etoposide—uterine cancer	0.000495	0.00392	CcSEcCtD
Secobarbital—Agitation—Epirubicin—uterine cancer	0.000491	0.0039	CcSEcCtD
Secobarbital—Rash—Etoposide—uterine cancer	0.00049	0.00389	CcSEcCtD
Secobarbital—Dermatitis—Etoposide—uterine cancer	0.00049	0.00389	CcSEcCtD
Secobarbital—Headache—Etoposide—uterine cancer	0.000487	0.00387	CcSEcCtD
Secobarbital—Tension—Doxorubicin—uterine cancer	0.000485	0.00385	CcSEcCtD
Secobarbital—Nervousness—Doxorubicin—uterine cancer	0.00048	0.00381	CcSEcCtD
Secobarbital—Syncope—Epirubicin—uterine cancer	0.000479	0.0038	CcSEcCtD
Secobarbital—Loss of consciousness—Epirubicin—uterine cancer	0.00047	0.00373	CcSEcCtD
Secobarbital—Nausea—Etoposide—uterine cancer	0.000462	0.00367	CcSEcCtD
Secobarbital—Agitation—Doxorubicin—uterine cancer	0.000454	0.0036	CcSEcCtD
Secobarbital—Anxiety—Epirubicin—uterine cancer	0.000453	0.0036	CcSEcCtD
Secobarbital—Syncope—Doxorubicin—uterine cancer	0.000443	0.00352	CcSEcCtD
Secobarbital—Confusional state—Epirubicin—uterine cancer	0.00044	0.00349	CcSEcCtD
Secobarbital—Loss of consciousness—Doxorubicin—uterine cancer	0.000434	0.00345	CcSEcCtD
Secobarbital—Shock—Epirubicin—uterine cancer	0.000429	0.0034	CcSEcCtD
Secobarbital—Anxiety—Doxorubicin—uterine cancer	0.000419	0.00333	CcSEcCtD
Secobarbital—Hypotension—Epirubicin—uterine cancer	0.000407	0.00323	CcSEcCtD
Secobarbital—Confusional state—Doxorubicin—uterine cancer	0.000407	0.00323	CcSEcCtD
Secobarbital—Shock—Doxorubicin—uterine cancer	0.000397	0.00315	CcSEcCtD
Secobarbital—Somnolence—Epirubicin—uterine cancer	0.000388	0.00308	CcSEcCtD
Secobarbital—Hypotension—Doxorubicin—uterine cancer	0.000377	0.00299	CcSEcCtD
Secobarbital—Constipation—Epirubicin—uterine cancer	0.000373	0.00296	CcSEcCtD
Secobarbital—Feeling abnormal—Epirubicin—uterine cancer	0.000359	0.00285	CcSEcCtD
Secobarbital—Somnolence—Doxorubicin—uterine cancer	0.000359	0.00285	CcSEcCtD
Secobarbital—Constipation—Doxorubicin—uterine cancer	0.000345	0.00274	CcSEcCtD
Secobarbital—Body temperature increased—Epirubicin—uterine cancer	0.000345	0.00273	CcSEcCtD
Secobarbital—Feeling abnormal—Doxorubicin—uterine cancer	0.000332	0.00264	CcSEcCtD
Secobarbital—Hypersensitivity—Epirubicin—uterine cancer	0.000321	0.00255	CcSEcCtD
Secobarbital—Body temperature increased—Doxorubicin—uterine cancer	0.000319	0.00253	CcSEcCtD
Secobarbital—Hypersensitivity—Doxorubicin—uterine cancer	0.000297	0.00236	CcSEcCtD
Secobarbital—Dizziness—Epirubicin—uterine cancer	0.000288	0.00229	CcSEcCtD
Secobarbital—Vomiting—Epirubicin—uterine cancer	0.000277	0.0022	CcSEcCtD
Secobarbital—Rash—Epirubicin—uterine cancer	0.000275	0.00218	CcSEcCtD
Secobarbital—Dermatitis—Epirubicin—uterine cancer	0.000275	0.00218	CcSEcCtD
Secobarbital—Headache—Epirubicin—uterine cancer	0.000273	0.00217	CcSEcCtD
Secobarbital—Dizziness—Doxorubicin—uterine cancer	0.000267	0.00212	CcSEcCtD
Secobarbital—Nausea—Epirubicin—uterine cancer	0.000259	0.00205	CcSEcCtD
Secobarbital—Vomiting—Doxorubicin—uterine cancer	0.000256	0.00204	CcSEcCtD
Secobarbital—Rash—Doxorubicin—uterine cancer	0.000254	0.00202	CcSEcCtD
Secobarbital—Dermatitis—Doxorubicin—uterine cancer	0.000254	0.00202	CcSEcCtD
Secobarbital—Headache—Doxorubicin—uterine cancer	0.000253	0.00201	CcSEcCtD
Secobarbital—Nausea—Doxorubicin—uterine cancer	0.00024	0.0019	CcSEcCtD
